Agile Therapeutics exploring funding options after FDA meeting

(Reuters) - Agile Therapeutics Inc said on Friday it was looking for ways to fund operations after a meeting with the U.S. health regulator raised the possibility of a new clinical trial to test its stick-on contraceptive patch, Twirla.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news